![Stephan Christgau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephan Christgau
Vorsitzender bei
Venture Cup Foundation
Profil
Stephan Christgau currently works at Venture Cup Foundation, as Chairman, Octarine Bio ApS, as Chairman from 2020, Life Science Legal ApS, as Director, IO Biotech ApS, as Director, Scenic Biotech BV, as Non-Executive Director, Eir Ventures Danmark ApS, as Managing Partner from 2020, and Eir Ventures Partners AB, as General Partner from 2020.
Dr. Christgau also formerly worked at Thrombologic ApS, as Chairman, PCOVERY ApS, as Chairman, Organon R&D Finland Oy, as Chairman from 2013 to 2020, EpiTherapeutics ApS, as Director, Inagen ApS, as Director, Aros Pharma ApS, as Director, Adenium Biotech ApS, as Director, Acesion Pharma ApS, as Director, Galecto Biotech ApS, as Director, Lysogene SA, as Executive Director, NMD Pharma A, as Director, HepaRegeniX GmbH, as Director, AFYX Therapeutics AS, as Director, Novo Holdings A, as Investment Director from 2017 to 2019, Damora Therapeutics, Inc., as Director from 2020 to 2021, Novo Nordisk A, as Research Scientist, Osteologix, Inc., as Chief Operating Officer & Secretary, Osteometer Biotech AS, as Senior Research Scientist, Osteologix Holdings Plc, as Chief Operating Officer & Executive Vice President, Immunodiagnostic Systems Nordic A, as Senior Research Scientist, and Novo Seeds, as Partner from 2007 to 2019.
Dr. Christgau received his doctorate degree from The University of California, San Francisco and graduate degree from Technical University of Denmark.
Aktive Positionen von Stephan Christgau
| Unternehmen | Position | Beginn |
|---|---|---|
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology Develops disruptive immune therapies | Direktor/Vorstandsmitglied | - |
Venture Cup Foundation | Vorsitzender | - |
Octarine Bio IVS
 Octarine Bio IVS BiotechnologyHealth Technology Manufactures bio-based pigments, dyes and ingredients using synthetic biology & precision fermentation | Vorsitzender | 30.06.2020 |
Eir Ventures Danmark ApS
 Eir Ventures Danmark ApS Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01.07.2020 |
iSD Immunotech ApS
 iSD Immunotech ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in natural sciences & engineering | Direktor/Vorstandsmitglied | - |
Scenic Biotech BV
 Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Develops therapies for patients using genomics | Direktor/Vorstandsmitglied | - |
Eir Ventures Partners AB
 Eir Ventures Partners AB Investment ManagersFinance Eir Ventures Partners invests in companies located in Sweden. The firm targets companies operating in the fields of life science, medical technology, new therapies and digital health service sectors. It provides financing for pre-seed, seed and early stage capital requirements. | Private Equity Investor | 01.01.2020 |
Ehemalige bekannte Positionen von Stephan Christgau
| Unternehmen | Position | Ende |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 26.05.2021 |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Vorsitzender | 01.07.2020 |
| ░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Stephan Christgau
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
20
Beziehungen ersten Grades
30
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 30 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Osteologix, Inc. /Old/
 Osteologix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Osteometer Biotech AS
 Osteometer Biotech AS BiotechnologyHealth Technology Develops treatments for bone disorders | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Operates as an investment holding company with interest in development of pharmaceuticals | Health Technology |
Immunodiagnostic Systems Nordic A/S
 Immunodiagnostic Systems Nordic A/S Medical SpecialtiesHealth Technology Develops diagnostic testing kits for clinical and research markets | Health Technology |
EpiTherapeutics ApS
 EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Health Technology |
Inagen ApS
 Inagen ApS Miscellaneous Commercial ServicesCommercial Services Develops novel biopharmaceuticals for anti-viral treatment and provides medical research services | Commercial Services |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds invests in companies located in Europe and the United States. The fund targets companies operating in the fields of life science and healthcare technology sectors. It provides financing for seed and early stage capital requirement. | Finance |
Venture Cup Foundation | |
Thrombologic ApS
 Thrombologic ApS Miscellaneous Commercial ServicesCommercial Services Provides medical research and develops therapeutics | Commercial Services |
Aros Pharma ApS
 Aros Pharma ApS Pharmaceuticals: MajorHealth Technology Develops a therapy for the treatment of gastrointestinal pain | Health Technology |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of invasive fungal infections | Health Technology |
Adenium Biotech ApS
 Adenium Biotech ApS Pharmaceuticals: MajorHealth Technology Provides novel antibiotics for the treatment of multi drug resistant bacterial infections | Health Technology |
Acesion Pharma ApS
 Acesion Pharma ApS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures antiarrhythmic drugs for treatment of atrial fibrillation | Commercial Services |
iSD Immunotech ApS
iSD Immunotech ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in natural sciences & engineering | Commercial Services |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Health Technology |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology Develops disruptive immune therapies | Health Technology |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology Discovers and develops novel therapeutics for neuromuscular diseases | Health Technology |
HepaRegeniX GmbH
 HepaRegeniX GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel therapies for the treatment of acute and chronic liver diseases | Health Technology |
AFYX Therapeutics AS
 AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Develops therapies for patients using genomics | Commercial Services |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Octarine Bio IVS
Octarine Bio IVS BiotechnologyHealth Technology Manufactures bio-based pigments, dyes and ingredients using synthetic biology & precision fermentation | Health Technology |
Eir Ventures Partners AB
Eir Ventures Partners AB Investment ManagersFinance Eir Ventures Partners invests in companies located in Sweden. The firm targets companies operating in the fields of life science, medical technology, new therapies and digital health service sectors. It provides financing for pre-seed, seed and early stage capital requirements. | Finance |
Eir Ventures Danmark ApS
Eir Ventures Danmark ApS Investment ManagersFinance Functions as an alternative investment manager | Finance |
